Calithera Biosciences OverviewCalithera Biosciences Research & Development
Research & Development expenses for CALA.
Quarterly R&D Expenses
$4.76M
↓ 65.34% YoY
As of Dec 31, 2022
Annual R&D Expenses (TTM)
$28.53M
↓ 46.62% YoY
Trailing 12 months ending Dec 31, 2022